{"id":"W4220660991","doi":"10.1007/s12022-022-09708-2","title":"Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms","year":2022,"lang":"en","type":"review","venue":"Endocrine Pathology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":957,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Neuroendocrine tumors; Neuroendocrine differentiation; Grading (engineering); Chromogranin A; MEN1; Biology; Pathology; Synaptophysin; Somatostatin receptor; Somatostatin; Hormone; Endocrine system; Medicine; Immunohistochemistry; Neuroscience; Internal medicine; Endocrinology; Cancer; Prostate cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1308989411007658,"score_gpt":0.4156465789728535,"score_spread":0.2847476378720876,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}